Senti Biosciences is trading 8.53% down now at $0.41, with no confirmed company-specific catalyst identified.
- Available coverage identifies no new August 17 announcement directly explaining the decline. Latest notable items are second-quarter results released August 14 and an August 18 annual meeting.
- The meeting includes votes on a proposed merger and reverse stock split; shares closed at $0.45 on August 14 after gaining 16.93%.
- Volume is 608.6K shares versus a 182.69K average daily volume; major indexes are only modestly lower.